NF-1819

CAS No. 1881244-28-5

NF-1819( —— )

Catalog No. M34346 CAS No. 1881244-28-5

NF-1819 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 55 Get Quote
10MG 92 Get Quote
25MG 182 Get Quote
50MG 329 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NF-1819
  • Note
    Research use only, not for human use.
  • Brief Description
    NF-1819 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor.
  • Description
    MGL-IN-1 is a potent and selective irreversible MGL (β-lactam-based monoacylglycerol lipase) inhibitor. MGL-IN-1 alleviates symptoms in a MS model in vivo and exhibits analgesic effects in an acute inflammatory pain model in vivo. MGL-IN-1 displays high membrane permeability and brain penetrant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Lipase
  • Recptor
    Lipase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1881244-28-5
  • Formula Weight
    463.46
  • Molecular Formula
    C24H22FN5O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (134.86 mM; Ultrasonic )
  • SMILES
    [H][C@@]1(N(C2CCN(CC2)C(=O)n2cncn2)C(=O)[C@]1([H])c1ccc(F)cc1)c1ccc2OCOc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Brindisi M, et al. Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain. J Med Chem. 2016 Mar 24;59(6):2612-32. ?
molnova catalog
related products
  • JW 642

    JW 642 is an effective inhibitor of monoacylglycerol lipase (MAGL)

  • JZP-361

    JZP-361 is a specific MAGL inhibitor with IC50s of 46 nM, 7.24 μM, and 1.79 μM for human recombinant MAGL, human recombinant FAAH, and human hABHD6.

  • Nolatrexed

    Nolatrexed is a thymidylate synthase inhibitor with potential anticancer activity.